Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.

Smith Byrne K. et al, (2019), Ann Oncol

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.

Preston MA. et al, (2019), Eur Urol, 75, 399 - 407

Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7.

Vickers AJ. et al, (2019), Eur Urol, 75

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.

Hugosson J. et al, (2019), Eur Urol

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.

Bancroft EK. et al, (2019), BJU Int, 123, 284 - 292

Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer.

Thorek DLJ. et al, (2019), Clin Cancer Res, 25, 881 - 891

A urinary extracellular vesicle microRNA biomarker discovery pipeline; from automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing.

Ku A. et al, (2019), PLoS One, 14

Clinical Chemistry's Special Issue on Men's Health.

Park JY. et al, (2019), Clin Chem, 65, 1 - 3

Perspective on Prostate Cancer Screening.

Carlsson SV. and Lilja H., (2019), Clin Chem, 65, 24 - 27

Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.

Srinivasan S. et al, (2019), Clin Chem, 65, e1 - e9

Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.

Li W. et al, (2018), Eur Urol, 74, 710 - 719

A functional variation in PSA (KLK3) gene that confers lower risk is also associated with more aggressive disease and lower survival in men with prostate cancer

Batra J. et al, (2018), BJU INTERNATIONAL, 122, 23 - 23

A novel two-step tumor cell isolation system, combining acoustophoresis and negative selection of white blood cells using CD45-conjugated elastomeric particles.

Magnusson C. et al, (2018), CANCER RESEARCH, 78, 38 - 39

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.

Kallio HML. et al, (2018), Br J Cancer, 119, 347 - 356

Early, highly specific risk stratification for lethal prostate cancer using a prespecified statistical model based on four kallikrein markers in blood.

Lilja H., (2018), CANCER RESEARCH, 78, 18 - 19

Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial.

Frånlund M. et al, (2018), Scand J Urol, 52, 256 - 262

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.

Vickers A. et al, (2018), Eur Urol, 74, e35 - e36

Acoustic Enrichment of Extracellular Vesicles from Biological Fluids.

Ku A. et al, (2018), Anal Chem, 90, 8011 - 8019

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.

Assel M. et al, (2018), Eur Urol, 73, 961 - 967

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?